Hi {{lead.First Name:default=edit me}},

You can obtain leukopaks (and other human biospecimens) from patients with confirmed autoimmune and infectious disease. That gives you up to 10 billion PBMCs for assays or process development from the same donor, delivered fresh or cryopreserved. Understand the whole patient with Sanguine’s patient-centric approach, including clinical annotation, HLA typing, a certificate of analysis, test results, and other associated metadata.

We’re helping you deliver better treatments for the 60,000+ patients in our network. Please check out our leukopaks page to learn whether these products bolster your cell & gene therapy development program.

Warm regards,

Charlene Christman
Vice President
Sanguine Biosciences | Massachusetts

| www.sanguinebio.com